SCHEMBL13488294

SCHEMBL13488294

Cc1ccc2c(-c3cccc4ccccc34)c3ccccc3c(-c3ccc4c(c3)N(C)c3ccccc3C=C4)c2c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
KDM4E B2RXH2 2/20 0.35
NPC1 O15118 1/20 0.35
NSD2 O96028 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35
RAD52 P43351 1/20 0.35
RECQL P46063 1/20 0.35
MMP14 P50281 1/20 0.35
RAB9A P51151 1/20 0.35
BLM P54132 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
FLT3 P36888 1/20 0.35
MAOA P21397 2/20 0.33
MAOB P27338 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13488292 0.89 MEN1 (0.35) POLBMEN1KMT2AKDM4ENPC1
SCHEMBL13488284 0.88 AKT1 (0.39) POLBMEN1KMT2AKDM4ENPC1
SCHEMBL13488314 0.88 AKT1 (0.38) POLBMEN1KMT2AKDM4EFLT3
SCHEMBL13488288 0.86 MEN1 (0.39) POLBMEN1KMT2AKDM4ENPC1
SCHEMBL13488291 0.85 MEN1 (0.38) POLBMEN1KMT2AKDM4ENPC1
SCHEMBL13487089 0.84 KDM4E (0.32) POLBMEN1KMT2AKDM4ENPC1
SCHEMBL13488329 0.83 MAOA (0.41) POLBMEN1KMT2AKDM4ELMNA
SCHEMBL13488297 0.82 HTR2C (0.33) POLBKDM4EMAPTRAB9ASMN1; SMN2
SCHEMBL13488304 0.82 MEN1 (0.37) POLBMEN1KMT2AKDM4ENPC1
SCHEMBL13488285 0.82 CYP11B1 (0.37) KMT2AKDM4ELMNAMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 POLB 1819/4885MEN1 3017/4885KMT2A 3530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.